1. Home
  2. CRL

as 06-30-2025 12:31pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Founded: 1947 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 7.1B IPO Year: 2000
Target Price: $186.38 AVG Volume (30 days): 832.4K
Analyst Decision: Hold Number of Analysts: 15
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.62 EPS Growth: N/A
52 Week Low/High: $91.86 - $254.15 Next Earning Date: 08-06-2025
Revenue: $4,022,597,000 Revenue Growth: -2.17%
Revenue Growth (this year): -2.81% Revenue Growth (next year): 2.49%

CRL Daily Stock ML Predictions

Stock Insider Trading Activity of Charles River Laboratories International Inc. (CRL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
MASSARO GEORGE CRL Director May 15 '25 Sell $137.68 140 $19,260.48 5,575
MASSARO GEORGE CRL Director May 14 '25 Sell $142.38 140 $19,702.90 5,575
LaPlume Joseph W CRL EVP, Corp Strategy & Develop May 13 '25 Sell $145.41 500 $72,705.00 19,513

Share on Social Networks: